BEL-14981-78318
4 vaccinations
1 coded response
38 check-ins
1 free-text entry
1 call case
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 273 / NC
- Registered
- 2020-12-29
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-29
Registered in v-safe
-
2020-12-29
Dose 1 — Moderna
- 2020-12-29
- 2020-12-30
- 2020-12-31
- 2021-01-01
- 2021-01-02
- 2021-01-04
- 2021-01-06
- 2021-01-13
- 2021-01-20
-
2021-01-26
Dose 2 — Moderna
- 2021-01-26
-
2021-01-27
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Swelling · Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesAdult check-in
- 2021-01-29
- 2021-01-31
- 2021-02-01
- 2021-02-02
- 2021-02-09
- 2021-02-16
- 2021-02-23
- 2021-03-02
- 2021-03-09
-
2021-04-27
Survey response — 3 months, dose 2MedDRA: Delivery, Postpartum state — Feeling: Good · Get care from a doctor or other healthcare professional · HospitalizationFree text: Symptoms: Postpartum · Healthcare visit (other): Uneventful vaginal deliveryMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-27
Report sent to call center — 3 months, dose 2Get care from a doctor or other healthcare professional1 call case(s)
-
2021-05-19
Call successfulNot applicable (accidental reporting or does not believe symptoms are related to vaccine)
- 2021-07-27
-
2021-11-17
Dose 3 — Moderna
- 2022-01-26
- 2022-05-18
-
2022-10-20
Dose 4 — Pfizer-BioNTech
-
2022-10-20
Health check-in — day 0, dose 4Feeling: Good · Site: Pain · Chills, Headache, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
- 2022-10-21
-
2022-10-22
Health check-in — days 1–6 daily, dose 4Feeling: Good · Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
- 2022-10-24
- 2022-10-25
- 2022-10-26
- 2022-10-27
- 2022-11-03
- 2022-11-10
- 2022-11-17
- 2022-11-26
- 2022-12-01
- 2023-01-19
- 2023-04-24
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-29 | Moderna | |
| 2 | 2021-01-26 | Moderna | |
| 3 | 2021-11-17 | Moderna | No |
| 4 | 2022-10-20 | Pfizer-BioNTech | No |
Call center
1 call center case
1 successful
Free text
Release 8 — 3 months, dose 2
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Delivery | ✓ | ✓ | ✓ |
| SD | Postpartum state | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release